A Study of a Single Intravenous Infusion Dose of TAK-925 in Participants With Idiopathic Hypersomnia

NCT04091438 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Idiopathic Hypersomnia

Interventions

DRUG: TAK-925
DRUG: TAK-925 Placebo

Sponsor

Millennium Pharmaceuticals, Inc.